Skip to main content

Arthropathy of Knee

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Stryker
StrykerCA - San Jose
2 programs
Scorpio® CR Total Knee SystemN/A1 trial
Triathlon All-Polyethylene Tibia KneeN/A1 trial
Active Trials
NCT00965146Terminated215
NCT04636190Active Not Recruiting204Est. Oct 2033
Exactech
ExactechFL - Gainesville
1 program
Optetrak PSN/A1 trial
Active Trials
NCT00808613Withdrawn0Est. Jan 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
StrykerTriathlon All-Polyethylene Tibia Knee
ExactechOptetrak PS
StrykerScorpio® CR Total Knee System

Clinical Trials (3)

Total enrollment: 419 patients across 3 trials

NCT04636190StrykerTriathlon All-Polyethylene Tibia Knee

Triathlon All-Polyethylene Tibia Outcomes Study

Start: Jul 2021Est. completion: Oct 2033204 patients
N/AActive Not Recruiting

Optetrak Posterior Stabilized Versus Optetrak Hi-Flex

Start: Dec 2008Est. completion: Jan 20120
N/AWithdrawn
NCT00965146StrykerScorpio® CR Total Knee System

Scorpio® Cruciate Retaining (CR) Outcomes Study

Start: Jun 2001215 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.